Developing novel antimicrobials by combining cancer chemotherapeutics with bacterial DNA repair inhibitors.
Cancer chemotherapeutics kill rapidly dividing cells, which includes cells of the immune system. The resulting neutropenia predisposes patients to infection, which delays treatment and is a major cause of morbidity and mortality. To tackle this problem, we have isolated several compounds that inhibi...
Saved in:
| Main Authors: | Lorenzo Bernacchia, Arya Gupta, Antoine Paris, Alexandra A Moores, Neil M Kad |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2023-12-01
|
| Series: | PLoS Pathogens |
| Online Access: | https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1011875&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tigecycline: Antimicrobial Action, Chemotherapeutic Efficacy and Adverse Reactions
by: A. V. Nikitin
Published: (2020-05-01) -
Base excision repair of chemotherapeutically-induced alkylated DNA damage predominantly causes contractions of expanded GAA repeats associated with Friedreich's ataxia.
by: Yanhao Lai, et al.
Published: (2014-01-01) -
Bacterial bio-cementation can repair space bricks
by: Nitin Gupta, et al.
Published: (2025-03-01) -
Combating antimicrobial resistance using antimicrobial combination therapy and β–lactamase inhibitors
by: Bassam El-Hafi, et al.
Published: (2018-02-01) -
Deitiforine, an Antiinfluenza Chemotherapeutic
by: S. N. Tandura, et al.
Published: (2020-05-01)